Mark Vesely, MD
Interventional Cardiology · Baltimore, MDNPI 1689715641
Payments from drug & device makers
What this record shows
23 manufacturers reported payments, led by Abbott at 25.4% of the total. Reporting peaked in 2019 at $2,990 and has fallen 73.4% since, to $794 in 2025. That places this record below the midpoint for interventional cardiology clinicians in MD, where the typical reported total is $7,370.
Across 110 payments — averaging $67.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Medtronic$2K
- Edwards Lifesciences$2K
- Medical Device Business Services, Inc.$1K
- Scpharmaceuticals Inc.$152
- Intuitive Surgical$86
- plus $759 from 17 others
Across 11 payments — averaging $3415.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$32K
- Abbott$6K
What the payments were for
- Travel & lodging$3,70950%
- Food & beverage$3,66150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 17 | $1,871 |
| Medtronic(2 entities) | 23 | $1,606 |
| Edwards Lifesciences | 15 | $1,599 |
| Medical Device Business Services, Inc. | 10 | $1,298 |
| Scpharmaceuticals Inc. | 4 | $152 |
| Intuitive Surgical | 1 | $86 |
| Pfizer | 4 | $85 |
| Boehringer Ingelheim | 4 | $77 |
| E.r. Squibb & Sons, L.L.C. | 5 | $76 |
| AstraZeneca | 4 | $74 |
| Esperion Therapeutics, Inc. | 3 | $64 |
| Z-medica, LLC | 2 | $58 |
| Siemens Medical Solutions USA, Inc. | 3 | $56 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $51 |
| Novo Nordisk | 2 | $43 |
| Novartis | 2 | $37 |
| Johnson & Johnson | 2 | $32 |
| Amgen | 1 | $25 |
| Inari Medical, Inc. | 1 | $23 |
| Bridgebio Pharma, Inc. | 1 | $16 |
| Bayer | 1 | $16 |
| GSK | 1 | $14 |
| Teleflex LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3 System$1,233
- EVOQUE$1,013
- Mitra Clip system$389
- PASCAL$163
- SYMPLICITY G3$150
- MitraClip System$111
- FUROSCIX$108
How this compares
$7,370 in reported general payments places this provider in the 50th percentile of 71 interventional cardiology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Baltimore
- Aloke FinnBaltimore$575K
- John WangBaltimore$138K
- Diljon ChahalBaltimore$78K
- Jon ResarBaltimore$40K
- Faisal RahmanBaltimore$36K
- Matthew VossBaltimore$33K
- Hooman BakhshiBaltimore$32K
- Daniel AmbinderBaltimore$32K
- Rani HasanBaltimore$22K
- Ajar KocharBaltimore$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.